LINC01915 and colorectal carcinoma: Mechanistic experiments showed that LINC01915 could regulate the miR-92a-3p/KLF4/CH25H axis and thus prevent angiogenesis and the conversion of NFs to CAFs and significantly inhibit the malignant progression of CRC (102) to inhibit the uptake of NFs to CRC-derived EVs.